{
  "nodes": [
    {
      "id": "CHEMBL:53463",
      "type": "Compound",
      "label": "Doxorubicin",
      "properties": {
        "molecular_formula": "C27H29NO11",
        "molecular_weight": 543.53,
        "max_phase": 4,
        "smiles": "COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1",
        "approved": "FDA (1974), EMA (1996)",
        "who_essential": true,
        "iuphar_id": "IUPHAR:7069"
      }
    },
    {
      "id": "HGNC:11990",
      "type": "Gene",
      "label": "TOP2B",
      "properties": {
        "name": "DNA topoisomerase II beta",
        "ensembl": "ENSG00000077097",
        "uniprot": "Q02880",
        "entrez": "7155",
        "location": "3p24.2",
        "function": "Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand. Plays a role in B-cell differentiation"
      }
    },
    {
      "id": "UniProtKB:Q02880",
      "type": "Protein",
      "label": "TOP2B",
      "properties": {
        "name": "DNA topoisomerase 2-beta",
        "organism": "Homo sapiens",
        "sequence_length": 1626,
        "string_id": "9606.ENSP00000264331",
        "biogrid_id": "113008"
      }
    },
    {
      "id": "HGNC:11180",
      "type": "Gene",
      "label": "SOD2",
      "properties": {
        "name": "superoxide dismutase 2",
        "ensembl": "ENSG00000291237",
        "uniprot": "P04179",
        "entrez": "6648",
        "location": "6q25.3",
        "alias": "MnSOD",
        "function": "Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems"
      }
    },
    {
      "id": "UniProtKB:P04179",
      "type": "Protein",
      "label": "SOD2",
      "properties": {
        "name": "Superoxide dismutase [Mn], mitochondrial",
        "organism": "Homo sapiens",
        "sequence_length": 222,
        "string_id": "9606.ENSP00000446252",
        "biogrid_id": "112531"
      }
    },
    {
      "id": "HGNC:4553",
      "type": "Gene",
      "label": "GPX1",
      "properties": {
        "name": "glutathione peroxidase 1",
        "ensembl": "ENSG00000233276",
        "uniprot": "P07203",
        "entrez": "2876",
        "location": "3p21.31",
        "function": "Catalyzes the reduction of hydroperoxides in a glutathione-dependent manner thus regulating cellular redox homeostasis"
      }
    },
    {
      "id": "UniProtKB:P07203",
      "type": "Protein",
      "label": "GPX1",
      "properties": {
        "name": "Glutathione peroxidase 1",
        "organism": "Homo sapiens",
        "sequence_length": 203,
        "biogrid_id": "109134"
      }
    },
    {
      "id": "EFO:0000318",
      "type": "Disease",
      "label": "Cardiomyopathy",
      "properties": {
        "source": "Open Targets"
      }
    },
    {
      "id": "CHEMBL:1200778",
      "type": "Compound",
      "label": "Dexrazoxane Hydrochloride",
      "properties": {
        "mechanism": "DNA topoisomerase II inhibitor",
        "max_phase": 4,
        "cardioprotective": true
      }
    },
    {
      "id": "NCT:07349459",
      "type": "ClinicalTrial",
      "label": "Cardioprotective Effect of Melatonin Versus Vitamin D",
      "properties": {
        "title": "Clinical Study Evaluating Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin",
        "status": "NOT_YET_RECRUITING",
        "study_type": "INTERVENTIONAL",
        "primary_purpose": "PREVENTION",
        "phase": null,
        "start_date": "2026-04-30"
      }
    },
    {
      "id": "NCT:04461223",
      "type": "ClinicalTrial",
      "label": "Myocardial Injury After Anthracycline Chemotherapy",
      "properties": {
        "title": "Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR",
        "status": "UNKNOWN",
        "study_type": "OBSERVATIONAL",
        "conditions": ["Cardiotoxicity", "Doxorubicin Induced Cardiomyopathy"],
        "start_date": "2019-12-01"
      }
    }
  ],
  "edges": [
    {
      "source": "HGNC:11990",
      "target": "UniProtKB:Q02880",
      "type": "ENCODES",
      "properties": {
        "evidence": "HGNC cross-reference"
      }
    },
    {
      "source": "HGNC:11180",
      "target": "UniProtKB:P04179",
      "type": "ENCODES",
      "properties": {
        "evidence": "HGNC cross-reference"
      }
    },
    {
      "source": "HGNC:4553",
      "target": "UniProtKB:P07203",
      "type": "ENCODES",
      "properties": {
        "evidence": "HGNC cross-reference"
      }
    },
    {
      "source": "CHEMBL:53463",
      "target": "UniProtKB:Q02880",
      "type": "INHIBITOR",
      "properties": {
        "mechanism": "DNA topoisomerase II inhibitor",
        "evidence": "IUPHAR, ChEMBL"
      }
    },
    {
      "source": "CHEMBL:1200778",
      "target": "UniProtKB:Q02880",
      "type": "INHIBITOR",
      "properties": {
        "mechanism": "DNA topoisomerase II inhibitor",
        "cardioprotective": true,
        "evidence": "Open Targets"
      }
    },
    {
      "source": "CHEMBL:53463",
      "target": "EFO:0000318",
      "type": "CAUSES",
      "properties": {
        "side_effect": "Cardiotoxicity",
        "evidence": "ClinicalTrials.gov (NCT04461223)"
      }
    },
    {
      "source": "HGNC:11990",
      "target": "EFO:0000318",
      "type": "ASSOCIATED_WITH",
      "properties": {
        "score": 0.465,
        "evidence": "Open Targets"
      }
    },
    {
      "source": "UniProtKB:Q02880",
      "target": "UniProtKB:Q02880",
      "type": "INTERACTS",
      "properties": {
        "partner": "TOP2A",
        "score": 0.973,
        "evidence": "STRING"
      }
    },
    {
      "source": "UniProtKB:Q02880",
      "target": "PARP1",
      "type": "INTERACTS",
      "properties": {
        "score": 0.724,
        "evidence": "STRING"
      }
    },
    {
      "source": "NCT:07349459",
      "target": "CHEMBL:53463",
      "type": "STUDIES",
      "properties": {
        "intervention": "Evaluating cardioprotective interventions",
        "status": "NOT_YET_RECRUITING"
      }
    },
    {
      "source": "NCT:04461223",
      "target": "CHEMBL:53463",
      "type": "STUDIES",
      "properties": {
        "intervention": "CMR evaluation of myocardial injury",
        "conditions": ["Cardiotoxicity", "Doxorubicin Induced Cardiomyopathy"]
      }
    }
  ],
  "metadata": {
    "query": "Doxorubicin cardiotoxicity mechanisms and side effects on heart cells",
    "generated_date": "2026-02-07",
    "protocol": "Fuzzy-to-Fact",
    "phases_completed": ["ANCHOR", "ENRICH", "EXPAND", "TRAVERSE_DRUGS", "TRAVERSE_TRIALS", "VALIDATE"],
    "source_databases": ["HGNC", "UniProt", "ChEMBL", "Open Targets", "STRING", "IUPHAR", "ClinicalTrials.gov"],
    "validated_entities": 11,
    "validated_relationships": 11
  }
}
